Skip to search formSkip to main contentSkip to account menu

Surfaxin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
New molecular entity: FDA approved lucinactant (Surfaxin, Discovery Laboratories) for the prevention of respiratory distress… 
2012
2012
A company’s drawn-out struggle to gain approval for a peptide therapy treating respiratory distress in preterm infants came to a… 
Review
2008
Review
2008
Respiratory distress syndrome (RDS) is a leading cause of mortality and morbidity in preterm infants. Surfactant replacement… 
2005
2005
Background: We have published results of two randomized, controlled trials comparing lucinactant (Surfaxin®), a new generation… 
2005
2005
Introduction: Supine sleeping is recommended to prevent sudden infant death syndrome (SIDS). Anecdotal evidence, however… 
2005
2005
Q: Are we doing any harm by giving antibiotics to the mother in preterm labor or to the preterm baby? Dr. Jobe: I do not think so… 
2004
2004
Background: Animal-derived, protein-containing surfactants perform better vs. non–protein-containing surfactants for the… 
2004
2004
Background: Animal-derived, protein-containing surfactants perform better vs. non–protein-containing surfactants for prevention…